Literature DB >> 22047566

Eliminating cells gone astray.

Michel Sadelain.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22047566     DOI： 10.1056/NEJMe1109971

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

2.  Metabolic engineering generates a transgene-free safety switch for cell therapy.

Authors:  Volker Wiebking; James O Patterson; Renata Martin; Monica K Chanda; Ciaran M Lee; Waracharee Srifa; Gang Bao; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2020-07-13       Impact factor: 54.908

Review 3.  Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.

Authors:  Alisa C Dong; Stefano Rivella
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  The basic principles of chimeric antigen receptor design.

Authors:  Michel Sadelain; Renier Brentjens; Isabelle Rivière
Journal:  Cancer Discov       Date:  2013-04-02       Impact factor: 39.397

5.  Novel approaches to enhance the specificity and safety of engineered T cells.

Authors:  Victor D Fedorov; Michel Sadelain; Christopher C Kloss
Journal:  Cancer J       Date:  2014 Mar-Apr       Impact factor: 3.360

Review 6.  Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.

Authors:  Dongfang Liu; Shuo Tian; Kai Zhang; Wei Xiong; Ndongala Michel Lubaki; Zhiying Chen; Weidong Han
Journal:  Protein Cell       Date:  2017-05-09       Impact factor: 14.870

Review 7.  Engineering chimeric antigen receptor-T cells for cancer treatment.

Authors:  Baixin Ye; Creed M Stary; Xuejun Li; Qingping Gao; Chunsheng Kang; Xiaoxing Xiong
Journal:  Mol Cancer       Date:  2018-02-15       Impact factor: 27.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.